Cumulative and bolus in vitro contracture testing with 4-chloro-3-ethylphenol in malignant hyperthermia positive and negative human skeletal muscles.
Mark Ulrich Gerbershagen, Marko Fiege, Ralf Weisshorn, Kerstin Kolodzie, Jochen Schulte am Esch, Frank Wappler
Index: Anesth. Analg. 101(3) , 710-4, table of contents, (2005)
Full Text: HTML
Abstract
In this study we evaluated the in vitro effects of 4-chloro-3-ethylphenol (CEP) using cumulative (12.5-200 micromol/L) or bolus (75 and 100 micromol/L) administrations, on muscle specimens from malignant hyperthermia (MH) susceptible and MH nonsusceptible patients, respectively. In the cumulative CEP in vitro contracture test, contractures were significantly greater in the MH susceptible compared with the MH nonsusceptible muscles in all concentrations between 25 and 100 micromol/L. There was no overlap between the diagnostic groups at 75 micromol/L of CEP, so this test appears to be feasible for diagnosis of MH susceptibility. The two bolus tests are not diagnostically useful, as overlaps between the diagnostic groups were observed.
Related Compounds
Related Articles:
The ryanodine receptor agonist 4-chloro-3-ethylphenol blocks ORAI store-operated channels.
2014-03-01
[Br. J. Pharmacol. 171(5) , 1250-9, (2014)]
1999-05-01
[Am. J. Physiol. 276(5 Pt 1) , L744-53, (1999)]
1997-10-01
[Br. J. Pharmacol. 122(3) , 504-10, (1997)]
1998-08-01
[Cell Calcium 24(2) , 105-15, (1998)]
2002-02-01
[Diabetes 51 Suppl 1 , S190-201, (2002)]